Radiomics for the noninvasive prediction of the BRAF mutation status in patients with melanoma brain metastases.
Meißner AK, Gutsche R, Galldiks N, Kocher M, Jünger ST, Eich ML, Montesinos-Rongen M, Brunn A, Deckert M, Wendl C, Dietmaier W, Goldbrunner R, Ruge MI, Mauch C, Schmidt NO, Proescholdt M, Grau S, Lohmann P.
Meißner AK, et al.
Neuro Oncol. 2022 Aug 1;24(8):1331-1340. doi: 10.1093/neuonc/noab294.
Neuro Oncol. 2022.
PMID: 34935978
Free PMC article.